Urinary Retention Following Inguinal Herniorrhaphy: Role of Neuromuscular Blockade Reversal. Issue 5 (October 2021)

• Record Type: Journal Article
• Authors: Valencia Morales, Diana J.; Stewart, Brody R.; Heller, Stephanie F.; Sprung, Juraj; Schroeder, Darrel R.; Ghanem, Omar M.; Weingarten, Toby N.
• Is Part Of: Surgical laparoscopy endoscopy & percutaneous techniques. Volume 31:Issue 5(2021)
• Publication Date: 2021-10
• Subjects: urinary retention herniorrhaphy -- glycopyrrolate-neostigmine -- sugammadex; Endoscopic surgery -- Periodicals; Laparoscopic surgery -- Periodicals; Endoscopy -- Periodicals; Laparoscopy -- Periodicals; 617.550597
• DOI: 10.1097/SLE.0000000000000962
• Languages: English
• ISSNs: 1530-4515

Abstract

Abstract : Background: Nondepolarizing neuromuscular blockade is reversed with neostigmine/glycopyrrolate or sugammadex. Anticholinergic glycopyrrolate decreases bladder detrusor muscle contractility, potentially leading to postoperative urinary retention (POUR). POUR commonly complicates inguinal herniorrhaphy. In this study we assess association between reversal technique and POUR. Methods: Records of adult patients undergoing unilateral inguinal herniorrhaphy with neuromuscular blockade from January 2013 to September 2020 were reviewed for POUR (unplanned postoperative insertion of urinary catheter). A propensity-adjusted analysis was performed to assess POUR in neostigmine/glycopyrrolate versus sugammadex using inverse probability of treatment weighting (IPTW) to adjust for potential confounding. Results: We identified 181 patients who underwent herniorrhaphy with amnio-steroidal neuromuscular blockers, 75 (41.4%) who received sugammadex and 106 (58.6%) neostigmine/glycopyrrolate. Compared with sugammadex, neostigmine/glycopyrrolate group had longer surgical course [unweighted standardized difference (USTD)=0.38, P =0.004], received more intraoperative opioids (USTD=0.704, P <0.001), more often performed via laparoscopic approach (USTD=0.407, P =0.012), and less often with periprocedural urinary catheter insertion (USTD=0.452, P =0.003). POUR was observed in 2 (3%) of patients in the sugammadex group, and 16 (15%) in neostigmine/glycopyrrolate [unadjusted odds ratio (OR)=0.15; 95% confidence interval (CI): 0.03-0.69; P =0.015, and IPTW OR=0.13; 95% CI: 0.03-0.64; P =0.012]. Results remained similar with further analysis adjusted for opioid administration in the postanesthesia care unit (adjusted IPTW OR=0.18; 95% CI: 0.04-0.88; P =0.034). Of the POUR patients, 9 required unplanned overnight admission and 4 emergency room visit. Conclusion: These results suggest that neuromuscular blockade reversal with sugammadex is associated with lower rates of POUR following unilateral inguinal herniorrhaphy. Our results need to be reconfirmed in a randomized prospective study.